Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols
- 1 May 2001
- journal article
- clinical trial
- Published by Elsevier BV in The Journal of Heart and Lung Transplantation
- Vol. 20 (5), 511-517
- https://doi.org/10.1016/s1053-2498(01)00244-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- OPTIMIZATION OF THE IMMUNOSUPPRESSIVE PROTOCOL AFTER LUNG TRANSPLANTATION1Transplantation, 1999
- The registry of the international society for heart and lung transplantation: sixteenth official report—1999The Journal of Heart and Lung Transplantation, 1999
- Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoringThe Journal of Heart and Lung Transplantation, 1999
- TacrolimusDrugs, 1997
- Clinical trial of tacrolimus versus cyclosporine in lung transplantationThe Annals of Thoracic Surgery, 1995
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995
- MAJOR INFECTIOUS COMPLICATIONS AFTER ORTHOTOPIC LIVER TRANSPLANTATION AND COMPARISON OF OUTCOMES IN PATIENTS RECEIVING CYCLOSPORINE OR FK506 AS PRIMARY IMMUNOSUPPRESSIONTransplantation, 1995
- Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantationThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Acute rejection of lung allografts with various immunosuppressive protocolsThe Annals of Thoracic Surgery, 1992
- Serum lipid abnormalities in heart transplant recipients: predominance of HDL2-like particles in the HDL patternAtherosclerosis, 1990